Our Partners

HEALTH SYSTEMS

Adverse drug-related problems account for 30% of hospitalization cases. Polypharmacy increases the risk of adverse drug events, low adherence and lowers treatment effectiveness.

PATIENTS

Current or new prescriptions make patients uneasy. Especially when having to go through the process of trial and error prescribing.

LONG TERM CARE

Patients admitted with a brown bag of 10 or more medications from potentially multiple physicians is challenging.

PHARMACIES

Pharmacists responsibilities grow at a compounding rate. Drug annotation label changes, for example, challenges the brightest Pharmacists.

PHYSICIANS

The common thread to precision personalized care begins with genetics

Dr. Jason Cavolina, BS, PharmD, MS

As President and CEO of RXVIP Enterprises, a company of pharmacists who consult patients at the point of care in the doctor's office. I had a need to qualify and select large groups of patients for pharmacogenetic testing (PGx). Basically, I needed a way to conduct risk assessments on large patient populations. We also needed a platform to allow PGx results to reside as a living document. Pro-GeneX met and exceeded all of our needs. I'm proud to be working with a leader in the risk assessment field!

What do my genetics have to do with medications? Watch this short video.

Pro-GeneX by Numbers

708

Drugs

150

Pathways

161

Dosing Guidelines

772

Drug Labels

The information above provided by PharmGKB.org which is a NIH NIGMS sponsored research project (GM61374) funded to collect, encode, and disseminate knowledge about the impact of human genetic variations on drug response.

Let's have a conversation.

TOP